Indians keep faith with Ganges despite pollution

For India's devout Hindus, the sacred River Ganges is always clean and always pure -- even if its waters are a toxic stew of human sewage, discarded garbage and factory waste. The belief
Source: RSS feed - channel BNewsHealth | 24 Jan 2010 | 1:09 am

High-end hotel boom sweeps Beirut

Beirut, one-time pearl of the Orient, is reclaiming its lustre, wooing some of the world's top luxury hotels to set up shop after a record year for tourism - and peace - in city once...
Source: RSS feed - channel BNewsHealth | 24 Jan 2010 | 12:32 am

Politics: Making a Healthy Lunch, and Making It a Cause

A Bay Area company grows by providing schools with nutritious meals in the fight against childhood obesity.


Source: NYT > Health | 24 Jan 2010 | 12:26 am

The Radiation Boom: Radiation Offers New Cures, and Ways to Do Harm

While new technology saves the lives of countless cancer patients, errors can lead to unspeakable pain and death.


Source: NYT > Health | 23 Jan 2010 | 11:07 pm

Heart Patients Warned Against Using Meridia, an Anti-Obesity Drug

European and American drug regulators had two starkly different reactions to data on an obesity drug.


Source: NYT > Health | 23 Jan 2010 | 9:52 pm

German taste for budget food worries producers

The French have a love affair with food, for the Italians a good meal is part of their cultural DNA, and even the British are increasingly particular about what passes their stiff upper...
Source: RSS feed - channel BNewsHealth | 23 Jan 2010 | 8:53 pm

Spotlight turns to Apple's 'latest creation'

The technology rumor mill is busy grinding speculation regarding an Apple event Wednesday at which the culture-changing firm will unveil its "latest creation." Expectation that the maker
Source: RSS feed - channel BNewsHealth | 23 Jan 2010 | 8:26 pm

Brain tumour

'I needed more than 30 doses of radiotherapy'
Source: BBC News | Health | World Edition | 23 Jan 2010 | 6:02 pm

Fake forms of Glaxo diet drug can be dangerous: FDA (Reuters)

Reuters - Fake versions of GlaxoSmithKline's over-the-counter diet pill were contaminated with dangerously high levels of a prescription weight loss ingredient, U.S. officials warned on Saturday.

Source: Yahoo! News: Health News | 23 Jan 2010 | 5:43 pm

Fake forms of Glaxo diet drug can be dangerous: FDA

WASHINGTON (Reuters) - Fake versions of GlaxoSmithKline's over-the-counter diet pill were contaminated with dangerously high levels of a prescription weight loss ingredient, U.S. officials...
Source: RSS feed - channel BNewsHealth | 23 Jan 2010 | 5:43 pm

RI company recalling 1.2M pounds of salami

A Rhode Island meat company is recalling 1.2 million pounds of pepper-coated salami due to concerns about salmonella contamination. The recall Saturday by Daniele International Inc....
Source: RSS feed - channel BNewsHealth | 23 Jan 2010 | 2:58 pm

Yodelling in the new year, Swiss style

Yodelling in the new year wearing a huge headdress and giant cowbells in the frozen countryside sounds more like comedy than a rite that reduces many Swiss to tears of nostalgic longing.
Source: RSS feed - channel BNewsHealth | 23 Jan 2010 | 1:31 pm

Jacques Tati back in Paris for Kenzo's 50s fashion

A swarm of vintage 50s Citroen DS cars and a bunch of lookalikes of Oscar-winning film-maker Jacques Tati took over an iconic Paris square on Saturday as Kenzo showed his latest menswear at
Source: RSS feed - channel BNewsHealth | 23 Jan 2010 | 9:19 am

Spyker 'well-positioned' to buy Saab-rival bidder

* Says outcome of talks with GM expected early next week
Source: RSS feed - channel BNewsHealth | 23 Jan 2010 | 7:30 am

Evolution Of Open Radical Retropubic Prostatectomy--how Have Open Surgeons Responded To The Challenge Of Minimally Invasive Surgery?

UroToday.com - Over the past seven to eight years there has been a proliferation of minimally invasive surgery (MIS) techniques for the treatment of urologic malignancies. This is no better demonstrated than the radical prostatectomy procedure for patients with prostate cancer. These clinical researchers undertook a unique survey study to assess the influence of MIS on open surgeons with regards to technique, surgical equipment, and perioperative management of patients undergoing surgery for urologic malignancies...

Source: Health News from Medical News Today | 23 Jan 2010 | 7:00 am

Engine had problem on A400M maiden flight-German magazine

BERLIN, Jan 23 (Reuters) - The Airbus A400M had an engine problem on its maiden flight last month, German magazine Spiegel said in an article on Saturday, citing documents from engine maker Europrop. ...
Source: RSS feed - channel BNewsHealth | 23 Jan 2010 | 3:12 am

When It Comes To Heart Health, Think About Your Lifestyle Habits

When it comes to heart health, whether or not your job is stressful isn't what you should be worried about, according to doctors at UT Southwestern Medical Center. Diet, exercise and risk factors like high cholesterol, smoking, diabetes, high blood pressure and obesity are what contribute to a person's chance of having a heart attack. "In my opinion, executives tend to be very organized and disciplined and often work exercise into their schedules," said Dr. James de Lemos, assistant professor of cardiology at UT Southwestern...

Source: Health News from Medical News Today | 23 Jan 2010 | 2:00 am

China Pharma Holdings, Inc. Completes Clinical Trials For Candesartan Anti-Hypertension Drug

China Pharma Holdings, Inc. ("China Pharma") (NYSE Amex: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China, announced that the Company has completed clinical trials for Candesartan, an anti-hypertension drug, and submitted the generic drug production application to the SFDA. Analysis of the clinical trial results shows that Candesartan Cilexetil is a prodrug of Candesartan...

Source: Health News from Medical News Today | 23 Jan 2010 | 2:00 am

Doctors Encourage Screening For Abdominal Aortic Aneurysm

Men ages 65 and older who have ever smoked should have a one-time, say cardiologists at UT Southwestern Medical Center. Men age 60 and older with a family history of abdominal aortic aneurysm should also consider screening. High blood pressure and a history of smoking can increase your chances of having an abdominal aortic aneurysm. "Aortic aneurysm ruptures are the 13th leading cause of death of men in the United States," says Dr. Frank Arko, a cardiac surgeon UT Southwestern. "They typically strike men over the age of 65...

Source: Health News from Medical News Today | 23 Jan 2010 | 2:00 am

Neuralstem Announces First Patient Treated In ALS Stem Cell Trial

Neuralstem, Inc. (NYSE Amex: CUR) announced that the first ALS patient was treated with its spinal cord stem cells yesterday at the Emory ALS Center at Emory University, in Atlanta, GA. A total of up to 18 patients is planned to be treated in this first U.S. clinical trial to evaluate human neural stem cells for the treatment of ALS (Amyotrophic Lateral Sclerosis, or Lou Gehrig's disease). ALS affects roughly 30,000 people in the U.S., with about 5,600 new diagnoses per year, according to the ALS Association...

Source: Health News from Medical News Today | 23 Jan 2010 | 2:00 am

Anadys Pharmaceuticals Provides Progress Update On Phase II Study Of ANA598 In Hepatitis C Patients

Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) announced that ANA598 dosing has been completed in the first dose cohort, 200 mg bid, in an ongoing Phase II study of ANA598 in combination with pegylated interferon and ribavirin (SOC) in HCV patients. Anadys expects to receive 12-week safety and antiviral response data for the 200 mg bid cohort in the first quarter of 2010. Anadys also announced that all patients have commenced dosing in the second dose cohort, 400 mg bid...

Source: Health News from Medical News Today | 23 Jan 2010 | 2:00 am

Pharmasset Initiates Phase 2a Trial With PSI-7977, A Chirally Pure Isomer Of PSI-7851

Pharmasset, Inc. (Nasdaq: VRUS) announces the initiation of a 28-day Phase 2a study with PSI-7977, a chirally pure isomer form of PSI-7851, a nucleotide analog polymerase inhibitor in development for the treatment of chronic hepatitis C (HCV). The trial will evaluate various doses of PSI-7977 in combination with Pegasys (peginterferon alfa 2a) and Copegus (ribavirin) in patients with HCV genotype 1 who have not been treated previously. "We recently reported encouraging clinical results with PSI-7851," said Michelle Berrey, MD, MPH, Pharmasset's Chief Medical Officer...

Source: Health News from Medical News Today | 23 Jan 2010 | 2:00 am

Heart Murmurs In Children: Not Always A Serious Problem

Your 3-year-old's doctor discovers a heart murmur during a visit for a mild cold with fever and recommends referral to a pediatric cardiologist. You worry and wonder how your healthy, active child could possibly have a heart problem. "Finding out that your child has a heart murmur causes a great deal of anxiety," said Dr. Louis Bezold, associate professor of pediatrics and chief of the division of pediatric cardiology, University of Kentucky College of Medicine, and co-director of the Kentucky Children's Heart Center...

Source: Health News from Medical News Today | 23 Jan 2010 | 2:00 am

Data From TNFerade(TM) Esophageal Cancer Study Presented At 2010 ASCO Gastrointestinal Cancer Symposium

GenVec, Inc. (Nasdaq: GNVC) announced that data from the Company's trial in esophageal cancer were presented at the American Society of Clinical Oncology's 2010 Gastrointestinal Cancer Symposium in Orlando, Florida on January 22, 2010. The poster, titled, "Long term survival analysis of multicenter clinical trial using endoscopy (END) and endoscopic ultrasound (EUS) guided fine needle injection (FNI) of antitumor agent (TNFerade Biologic (TNF)) in patients with locally advanced esophageal cancer," reports on updated efficacy and survival data...

Source: Health News from Medical News Today | 23 Jan 2010 | 2:00 am

New Plan Puts Heart Attacks On Fast Track

Heart attack patients won't go to the emergency room as part of a new University of Kentucky plan designed to reduce those patients' risk of dying by nearly 8 percent for every half hour shaved off the time between the ambulance and treatment at the hospital. In most cases, heart attack sufferers go straight to the cardiac catheterization lab in the UK Gill Heart Institute, where a specialized response team waits to break through the life-threatening blood clot that is causing the attack...

Source: Health News from Medical News Today | 23 Jan 2010 | 2:00 am